Disease Modifying Status Targeted As Kolon's Novel OA Therapy Enters US Phase III

 
• By Jung Won Shin
  
Osteoarthritis
Kolon Looks For Disease-Modifying Claim As Novel OA Therapy Set For US Phase III • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D